Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Elizabeth O'Day; Leticia Hosta-Rigau; Diego A. Oyarzún; Hideyuki Okano; Víctor de Lorenzo; Conrad von Kameke; Habiba Alsafar; Cong Cao; Guo Qiang Chen; Weizhi Ji; Richard J. Roberts; Mostafa Ronaghi; Karen Yeung; Feng Zhang; Sang Yup Lee

doi:10.1002/biot.201800195

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Elizabeth O'Day
, Leticia Hosta-Rigau
, Diego A. Oyarzún
, Hideyuki Okano
, Víctor de Lorenzo
, Conrad von Kameke
, Habiba Alsafar
, Cong Cao
, Guo Qiang Chen
, Weizhi Ji
, Richard J. Roberts
, Mostafa Ronaghi
, Karen Yeung
, Feng Zhang
, Sang Yup Lee

Biomedical Engineering & Biotechnology

World Economic Forum
Olaris Therapeutics, Inc.
Technical University of Denmark
Imperial College London
Keio University School of Medicine
Campus de Cantoblanco
BioInnovators Europe
The University of Nottingham Ningbo China
Peking University
Kunming University of Science and Technology
New England Biolabs
Illumina Inc.
University of Birmingham
Broad Institute
McGovern Institute
Massachusetts Institute of Technology
Department of Industrial and Systems Engineering Korea Advanced Institute of Science and Technology

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.

Original language	British English
Article number	1800195
Journal	Biotechnology Journal
Volume	14
Issue number	1
DOIs	https://doi.org/10.1002/biot.201800195
State	Published - Jan 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

biotechnology
gene editing
precision medicine
stem cells
tissue engineering

Access to Document

10.1002/biot.201800195

OpenUrl availability

Full text

Cite this

O'Day, E., Hosta-Rigau, L., Oyarzún, D. A., Okano, H., de Lorenzo, V., von Kameke, C., Alsafar, H., Cao, C., Chen, G. Q., Ji, W., Roberts, R. J., Ronaghi, M., Yeung, K., Zhang, F., & Lee, S. Y. (2019). Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health. Biotechnology Journal, 14(1), Article 1800195. https://doi.org/10.1002/biot.201800195

@article{a2704c1ae6564deb83a3afe7fc109687,

title = "Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health",

abstract = "Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.",

keywords = "biotechnology, gene editing, precision medicine, stem cells, tissue engineering",

author = "Elizabeth O'Day and Leticia Hosta-Rigau and Oyarz{\'u}n, \{Diego A.\} and Hideyuki Okano and \{de Lorenzo\}, V{\'i}ctor and \{von Kameke\}, Conrad and Habiba Alsafar and Cong Cao and Chen, \{Guo Qiang\} and Weizhi Ji and Roberts, \{Richard J.\} and Mostafa Ronaghi and Karen Yeung and Feng Zhang and Lee, \{Sang Yup\}",

note = "Publisher Copyright: {\textcopyright} 2018 WILEY-VCH Verlag GmbH \& Co. KGaA, Weinheim",

year = "2019",

month = jan,

doi = "10.1002/biot.201800195",

language = "British English",

volume = "14",

journal = "Biotechnology Journal",

issn = "1860-6768",

publisher = "Wiley-VCH Verlag",

number = "1",

}

TY - JOUR

T1 - Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

AU - O'Day, Elizabeth

AU - Hosta-Rigau, Leticia

AU - Oyarzún, Diego A.

AU - Okano, Hideyuki

AU - de Lorenzo, Víctor

AU - von Kameke, Conrad

AU - Alsafar, Habiba

AU - Cao, Cong

AU - Chen, Guo Qiang

AU - Ji, Weizhi

AU - Roberts, Richard J.

AU - Ronaghi, Mostafa

AU - Yeung, Karen

AU - Zhang, Feng

AU - Lee, Sang Yup

PY - 2019/1

Y1 - 2019/1

N2 - Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.

AB - Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.

KW - biotechnology

KW - gene editing

KW - precision medicine

KW - stem cells

KW - tissue engineering

UR - https://www.scopus.com/pages/publications/85058653031

U2 - 10.1002/biot.201800195

DO - 10.1002/biot.201800195

M3 - Review article

C2 - 29799175

AN - SCOPUS:85058653031

SN - 1860-6768

VL - 14

JO - Biotechnology Journal

JF - Biotechnology Journal

IS - 1

M1 - 1800195

ER -

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Abstract

UN SDGs

Keywords

Access to Document

OpenUrl availability

Other files and links

Fingerprint

Cite this